Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver.
D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D004852:Epoxy Compounds / Q000494:pharmacology*; D004988:Ethers, Cyclic / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism* / Q000494:pharmacology*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007657:Ketone Bodies / Q000096:biosynthesis; D007700:Kinetics; D008055:Lipids / Q000096:biosynthesis; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D019301:Oleic Acid; D009829:Oleic Acids / Q000378:metabolism; D010084:Oxidation-Reduction; D051381:Rats; D014280:Triglycerides / Q000378:metabolism*
D004852:Epoxy Compounds; D004988:Ethers, Cyclic; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D007657:Ketone Bodies; D008055:Lipids; D008079:Lipoproteins, VLDL; D009829:Oleic Acids; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride; D019301:Oleic Acid; D002784:Cholesterol; C021756:2-tetradecylglycidic acid